Gliclazide stimulates insulin secretion from pancreatic beta-cells, reduces insulin uptake and glucose output by the liver, and increases insulin sensitivity at peripheral target sites.

ZIDE belongs to the class of drug called oral hypoglycemic. It is used for the control of blood glucose in people with type 2 diabetes. It increases the amount of insulin released by the …

2025年1月7日 · Adult: The usual initial dose of Zideis 40 to 80 mg daily, gradually increased, if necessary up to 320 mg daily until adequate control is achieved. A single dose should not …

Zide stimulates insulin secretion from pancreatic beta-cells, reduces insulin uptake and glucose output by the liver, and increases insulin sensitivity at peripheral target sites.

ZIDE 40 belongs to the class of drug called oral hypoglycemic. It is used for the control of blood glucose in people with type 2 diabetes. It increases the amount of insulin released by the …

Find ZIDE Drug Product Composition and Inactive Ingredients for Set Id c8b18a0b-b4f7-4f88-8732-1fa4736c3046 and Form TABLET;ORAL and Dosage 12.5MG;40MG for ApplNo 21162.

Zide stimulates insulin secretion from pancreatic beta-cells, reduces insulin uptake and glucose output by the liver, and increases insulin sensitivity at peripheral target sites.

Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. Zide is a "water pill" (diuretic) that causes you to make more urine.

Gliclazide tablets are used to treat maturity onset diabetes in patients that is not controlled by diet alone. They are not for use in children or in patients with diabetes requiring insulin. The …

Get information about NID 40, its dosage information which are manufactured by Nepal Pharmaceuticals Laboratory Pvt. Ltd. (NPL).